Naringenin inhibits migration of lung cancer cells via the inhibition of matrix metalloproteinases-2 and -9

  • Authors:
    • Huai‑Lu Chang
    • Yuh‑Ming Chang
    • Shih‑Chan Lai
    • Ke‑Min Chen
    • Kuan‑Chu Wang
    • Tsu‑Ting Chiu
    • Fu‑Hsin Chang
    • Li‑Sung Hsu
  • View Affiliations

  • Published online on: December 22, 2016     https://doi.org/10.3892/etm.2016.3994
  • Pages: 739-744
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Lung cancer is among the most common causes of cancer‑related mortality. It has a high mortality rate and resistance to chemotherapy due to its high metastatic potential. Naringenin, a bioactive compound identified in several fruits, displays anti‑inflammatory and antitumor effects. Furthermore, naringenin mitigates the migration of several human cancer cell types. However, the effects of naringenin on lung cancer remain unclear. The current study investigated the mechanisms of naringenin on the migration of lung cancer A549 cells. The results indicate that significant alteration in A549 cell proliferation was observed in response to naringenin (0‑300 µM) treatment for 24 and 48 h. Furthermore, a dose‑dependent migration inhibition of A549 in the presence of naringenin was observed by healing and transwell migration assays. In addition, a zymography assay revealed that naringenin exhibited a concentration‑dependent inhibition of matrix metalloproteinase (MMP)‑2 and ‑9 activities. Furthermore, naringenin also inhibited the activities of AKT in a dose‑dependent manner. These observations indicated that naringenin inhibited the migration of lung cancer A549 cells through several mechanisms, including the inhibition of AKT activities and reduction of MMP-2 and -9 activities.

Related Articles

Journal Cover

February-2017
Volume 13 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chang HL, Chang YM, Lai SC, Chen KM, Wang KC, Chiu TT, Chang FH and Hsu LS: Naringenin inhibits migration of lung cancer cells via the inhibition of matrix metalloproteinases-2 and -9. Exp Ther Med 13: 739-744, 2017.
APA
Chang, H., Chang, Y., Lai, S., Chen, K., Wang, K., Chiu, T. ... Hsu, L. (2017). Naringenin inhibits migration of lung cancer cells via the inhibition of matrix metalloproteinases-2 and -9. Experimental and Therapeutic Medicine, 13, 739-744. https://doi.org/10.3892/etm.2016.3994
MLA
Chang, H., Chang, Y., Lai, S., Chen, K., Wang, K., Chiu, T., Chang, F., Hsu, L."Naringenin inhibits migration of lung cancer cells via the inhibition of matrix metalloproteinases-2 and -9". Experimental and Therapeutic Medicine 13.2 (2017): 739-744.
Chicago
Chang, H., Chang, Y., Lai, S., Chen, K., Wang, K., Chiu, T., Chang, F., Hsu, L."Naringenin inhibits migration of lung cancer cells via the inhibition of matrix metalloproteinases-2 and -9". Experimental and Therapeutic Medicine 13, no. 2 (2017): 739-744. https://doi.org/10.3892/etm.2016.3994